P034: Reduction of blood phenylalanine in participants enrolled in OPAL, an observational study, mirror findings from the US-based PRISM population

• Markey McNutt,
• Ogun Sazova,
• Karen Gu,
• Sarah Rose,
• Milad Karimi,
• Frank Rutsch,
• Ania Muntau

Affiliations

Markey McNutt

University of Texas Southwestern Medical Center

Ogun Sazova

BioMarin Europe Ltd., London, UK

Karen Gu

BioMarin Pharmaceutical Inc

Sarah Rose

BioMarin Pharmaceutical Inc

Milad Karimi

BioMarin Europe Ltd., London, UK

Frank Rutsch

Department of General Pediatrics, Muenster University Children’s Hospital, Muenster, Germany

Ania Muntau

University Children’s Hospital, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany